Lucas Chan – Scientific Founder & CSO, CellVec
Lucas Chan, Scientific Founder and CSO of CellVec, a Singapore-based CDMO that specializes in the development and manufacture of viral vectors for…
Tagged with Manufacturing
Haijun Dong – CEO, BioDuro-Sundia
Dr Haijun Dong, recently appointed CEO of BioDuro-Sundia, shares his priorities for the newly merged entity, one of the largest Contract Research,…
Marc-Olivier Geinoz – CEO, Dipharma SA
Dipharma SA is a Swiss specialty pharmaceutical company, developing improved generics medicines for rare metabolic diseases. Founder & CEO…
Top 5 Global CDMOs
As the global pharmaceutical industry continues to grow, so have opportunities for service providers. Over the last few decades, while big pharma…
Vaccines: Manufacturing & Supply Chain Complexity
Pharma industry insiders view vaccines as one of the most challenging products to manufacture, fundamentally due to the inherent biological…
Jacques Marbehant – Senior Vice President, Head of Global…
Belgian champion UCB's global manufacturing head, Jacques Marbehant, talks candidly about managing a broad global manufacturing and supply chain…
Reconsidering Cell & Gene Therapy Manufacturing
Advances in cell and gene therapies (CGT) are credited with thoroughly transforming medicinal science and creating an inflection point in the ability…
Alvotech’s Four Traits for Biosimilars Success
Alvotech – the biosimilars arm of Icelandic-headquartered generics player Alvogen – is positioning itself for future growth via a very different…
Michael Quirmbach – CEO & President, CordenPharma
The CEO & President of CDMO CordenPharma, Dr Michael Quirmbach, delves into the contract manufacturing industry, explaining the reasons behind the…
Anil Okay – General Manager, Adalvo & Chief Commercial…
CCO Anil Okay introduces how Alvotech’s focus on biosimilars, comprehensive platform, differentiated portfolio approach, and commercial strategy…
Marina Lugova – CFO & Member of the Board of…
Chief Financial Officer Marina Lugova introduces pharmaceutical company Synbias Pharma’s evolving European footprint, how the company has been able…
Growth, COVID-19 Response & Essential Medicines Industry…
Graeme Duncan, CEO of ADVANZ PHARMA, highlights how the specialty generics firm has revitalized its operations since 2018 both culturally and…
